Menu Back toGene Therapy Research in Pediatric Populations: Ethical Issues
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Gene Therapy Research in Pediatric Populations: Ethical Issues
Alison Bateman-House, PhD, MA, MPH
- Assistant Professor, Division of Medical Ethics, Dept of Population Health
- NYU Langone Health, United States
Many gene therapy trials enroll pediatric patients. Clinical research in children raises discrete ethical challenges, as does clinical research involving gene therapy; this forum identifies these challenges and identifies relevant guidance documents.
Learning Objective : Identify the primary ethical challenges facing pediatric gene therapy trials; Assess which ethical challenges are common to all clinical research in children versus which are unique to gene therapy trials in this population; Recognize existing ethical guidance on these issues.
Rafael Escandon, DrPH, PhD, MPH, MS
- Senior Vice President Medical Affairs, Policy and Patient Engagement
- Bridgebio Gene Therapy, United States
Alexandra Hall, MA
- Managing Director: Policy, Patient Support, and Industry
- The Isaac Foundation, Canada
Lesha D. Shah, MD, FAPA
- Assistant Professor; Medical Director
- Icahn School of Medicine at Mount Sinai, United States